T12	Exp 291 295	that
T13	Exp 179 209	the cytotoxic drug doxorubicin
T14	Exp 339 341	We
T15	Exp 359 363	that
T16	Exp 607 620	the influence
T17	Exp 746 815	the proteasome inhibitor N-acetyl-L-leucinyl-L-leucinyl-L-norleucinal
T18	Exp 933 949	these treatments
T19	Exp 1044 1048	that
T20	Exp 995 999	both
T21	Exp 1216 1220	that
T22	Exp 1197 1207	These data
R3	Coref Anaphora:T12 Antecedent:T23
R4	Coref Anaphora:T19 Antecedent:T24
T1	Protein 137 164	tumor necrosis factor alpha
T2	Protein 166 174	TNFalpha
T3	Protein 364 369	TRAIL
T4	Protein 371 408	TNF-related apoptosis-inducing ligand
T5	Protein 509 517	TNFalpha
T6	Protein 557 561	FADD
T7	Protein 667 672	TRAIL
T8	Protein 674 678	CD95
T9	Protein 680 688	TNFalpha
T10	Protein 854 866	IkappaBalpha
T23	Exp 273 290	dependent program
T24	Exp 1021 1043	primary leukemia cells
